- US-listed companies
- Bionik Laboratories Corp.
- Income statement
Bionik Laboratories Corp. (BNKL) Income statement
Market cap
$12.48
P/E ratio
| 2011/12 | 2015/12 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | |
| Revenue | - | - | 571,945 | 987,431 | - | - | 1 | 1 | 2 |
| Revenue growth (%) | - | - | - | - | - | - | |||
| Cost of revenue | - | - | 388,756 | 402,665 | 2 | 893,374 | 269,632 | 320,454 | 815,325 |
| Gross profit | - | - | 183,189 | 584,766 | 2 | 1 | 923,798 | 953,258 | 989,877 |
| Gross margin (%) | - | - | - | - | |||||
| Research & development | - | 1 | 3 | 3 | 3 | 4 | 1 | 998,516 | 903,219 |
| Operating margin (%) | - | - | - | - | - | - | |||
| Operating expenses | 26,249 | 6 | 9 | 10 | 11 | 12 | 14 | 11 | 6 |
| Operating income | -4,479 | - | - | - | - | - | -13,337,325 | -9,973,199 | -4,825,039 |
| Net income | -4,661 | -5,593,906 | -3,936,574 | -14,625,790 | 11 | 25 | -13,620,457 | -10,407,994 | -4,946,024 |
| Net income margin (%) | - | - | - | - | |||||
| Earnings per share | - | - | -0.04 | - | - | - | - | -1.78 | -0.72 |
| Diluted EPS | - | - | -0.04 | - | - | - | - | -1.78 | -0.72 |
| EBITDA | - | - | - | - | - | - | |||
| EBITDA margin (%) | - | - | - | - | - | - |